Patents by Inventor Javier GARCÍA CASADO

Javier GARCÍA CASADO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mesenchymal stem cell-derived exosomes and their uses
    Patent number: 11857575
    Abstract: The invention relates to exosomes derived from mesenchymal stem cells and well as isolated populations of said exosomes and method for preparing said isolated exosome populations. The invention also relates to a pharmaceutical composition comprising said exosome or isolated exosome population and their use in a method of treating an immune-mediated inflammatory disease in a subject.
    Type: Grant
    Filed: November 2, 2016
    Date of Patent: January 2, 2024
    Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Olga De La Rosa, Eleuterio Lombardo, Wilfried Dalemans, Javier Garcia Casado, Rebeca Blazquez Duran, Francisco Miguel Sanchez Margallo
  • MESENCHYMAL STEM CELL-DERIVED EXOSOMES AND THEIR USES
    Publication number: 20180318354
    Abstract: The invention relates to exosomes derived from mesenchymal stem cells and well as isolated populations of said exosomes and method for preparing said isolated exosome populations. The invention also relates to a pharmaceutical composition comprising said exosome or isolated exosome population and their use in a method of treating an immune-mediated inflammatory disease in a subject.
    Type: Application
    Filed: November 2, 2016
    Publication date: November 8, 2018
    Inventors: Olga De La Rosa, Eleuterio Lombardo, Wilfried Dalemans, Javier Garcia Casado, Rebeca Blazquez Duran, Francisco Miguel Sanchez Margallo
  • MESENCHYMAL STEM CELL-DERIVED EXOSOMES AND THEIR USES
    Publication number: 20170121685
    Abstract: The invention relates to exosomes derived from mesenchymal stem cells and well as isolated populations of said exosomes and method for preparing said isolated exosome populations. The invention also relates to a pharmaceutical composition comprising said exosome or isolated exosome population and their use in a method of treating an immune-mediated inflammatory disease in a subject.
    Type: Application
    Filed: November 2, 2015
    Publication date: May 4, 2017
    Inventors: Olga DE LA ROSA, Eleuterio LOMBARDO, Wilfried DALEMANS, Javier GARCÍA CASADO, Rebeca BLÁZQUEZ DURÁN, Francisco Miguel SÁNCHEZ MARGALLO,
  • MESENCHYMAL STEM CELL-DERIVED EXOSOMES AND THEIR USES
    Publication number: 20170119682
    Abstract: The invention relates to exosomes derived from mesenchymal stem cells and well as isolated populations of said exosomes and method for preparing said isolated exosome populations. The invention also relates to a pharmaceutical composition comprising said exosome or isolated exosome population and their use in a method of treating an immune-mediated inflammatory disease in a subject.
    Type: Application
    Filed: November 2, 2016
    Publication date: May 4, 2017
    Inventors: Olga De La Rosa, Eleuterio Lombardo, Wilfried Dalemans, Javier Garcia Casado, Rebeca Blazquez Duran, Francisco Miguel Sanchez Margallo
  • CELL POPULATIONS HAVING IMMUNOREGULATORY ACTIVITY, METHOD FOR ISOLATION AND USES
    Publication number: 20140154227
    Abstract: The present invention provides a population of mesenchymal cells that do not express the cell surface markers CD112 and/or CD155 for use in preventing, treating or ameliorating one or more symptoms associated with disorders in which modulation of a subject's immune system is beneficial, including, but not limited to, autoimmune diseases, inflammatory disorders, and immunologically mediated diseases including rejection of transplanted organs and tissues.
    Type: Application
    Filed: March 12, 2012
    Publication date: June 5, 2014
    Inventors: Javier Garcia Casado, Raquel Tarazona Lafarge, Olga De La Rosa